======= KEAP1 ======= == Gene Information == * **Official Symbol**: KEAP1 * **Official Name**: kelch like ECH associated protein 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9817|9817]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q14145|Q14145]] * **Interactions**: [[https://thebiogrid.org/search.php?search=KEAP1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KEAP1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606016|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Acts as a substrate adapter protein for the E3 ubiquitin ligase complex formed by CUL3 and RBX1 and targets NFE2L2/NRF2 for ubiquitination and degradation by the proteasome, thus resulting in the suppression of its transcriptional activity and the repression of antioxidant response element-mediated detoxifying enzyme gene expression. Retains NFE2L2/NRF2 and may also retain BPTF in the cytosol. Targets PGAM5 for ubiquitination and degradation by the proteasome. {ECO:0000269|PubMed:14585973, ECO:0000269|PubMed:15379550, ECO:0000269|PubMed:15572695, ECO:0000269|PubMed:15983046, ECO:0000269|PubMed:17046835}. |Kelch 2| |Kelch 1| |BTB| |BACK| |cytoplasmic sequestering of transcription factor| |cytoplasmic sequestering of protein| |proteasomal ubiquitin-independent protein catabolic process| |cellular response to interleukin-4| |response to interleukin-4| |disordered domain specific binding| |Cul3-RING ubiquitin ligase complex| |regulation of epidermal cell differentiation| |actin filament| |positive regulation of proteasomal ubiquitin-dependent protein catabolic process| |regulation of epidermis development| |positive regulation of ubiquitin-dependent protein catabolic process| |positive regulation of proteasomal protein catabolic process| |maintenance of protein location| |positive regulation of proteolysis involved in cellular protein catabolic process| |regulation of proteasomal ubiquitin-dependent protein catabolic process| |positive regulation of cellular protein catabolic process| |regulation of epithelial cell differentiation| |regulation of ubiquitin-dependent protein catabolic process| |microtubule organizing center| |midbody| |negative regulation of DNA-binding transcription factor activity| |maintenance of location| |regulation of proteasomal protein catabolic process| |regulation of proteolysis involved in cellular protein catabolic process| |positive regulation of protein catabolic process| |regulation of cellular protein catabolic process| |protein deubiquitination| |protein modification by small protein removal| |transcription factor binding| |proteasomal protein catabolic process| |positive regulation of proteolysis| |post-translational protein modification| |positive regulation of cellular catabolic process| |in utero embryonic development| |regulation of protein catabolic process| |regulation of DNA-binding transcription factor activity| |positive regulation of catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |chordate embryonic development| |embryo development ending in birth or egg hatching| |protein catabolic process| |protein ubiquitination| |viral process| |regulation of proteolysis| |protein modification by small protein conjugation| |symbiotic process| |interspecies interaction between organisms| |regulation of cellular catabolic process| |protein homodimerization activity| |cellular macromolecule catabolic process| |embryo development| |protein modification by small protein conjugation or removal| |regulation of catabolic process| |cellular response to cytokine stimulus| |endoplasmic reticulum| |macromolecule catabolic process| |organonitrogen compound catabolic process| |response to cytokine| |negative regulation of molecular function| |proteolysis| |positive regulation of cellular protein metabolic process| |positive regulation of protein metabolic process| |organic substance catabolic process| |cellular catabolic process| |regulation of cell differentiation| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp535|Trimetrexate 0.03μM R08 exp535]]|-2.75| |[[:results:exp498|Lead acetate 2000μM R08 exp498 no dilution day6]]|-2.72| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|-2.6| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|-2.55| |[[:results:exp497|Lead acetate 2000μM R08 exp497]]|-2.4| |[[:results:exp499|LY2090314 0.003μM R08 exp499]]|-2.32| |[[:results:exp414|Tozasertib 0.1μM R07 exp414]]|-2.28| |[[:results:exp184|Ixabepilone 0.004 to 0.005μM on day4 R04 exp184]]|-2.26| |[[:results:exp526|Sulforaphane 9μM R08 exp526 no dilution day6]]|-2.25| |[[:results:exp492|iCRT14 30μM R08 exp492]]|-2.2| |[[:results:exp407|Thapsigargin 0.005μM R07 exp407]]|-2.12| |[[:results:exp116|AICAR 240μM R03 exp116]]|-2.09| |[[:results:exp359|FK-506 30μM R07 exp359]]|-2.06| |[[:results:exp212|Phenformin 20μM R05 exp212]]|-1.98| |[[:results:exp438|NN-Diethyl-meta-toluamide 500μM R08 exp438]]|-1.93| |[[:results:exp73|LJH685 5μM R02 exp73]]|-1.93| |[[:results:exp72|LB-100 4.1μM R02 exp72]]|-1.92| |[[:results:exp223|Cabazitaxel 0.001μM R05 exp223]]|-1.84| |[[:results:exp405|Tenofovir 10μM R07 exp405]]|-1.83| |[[:results:exp351|Dexamethasone 0.006μM R07 exp351]]|-1.8| |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|-1.79| |[[:results:exp525|Sulforaphane 9μM R08 exp525]]|-1.79| |[[:results:exp176|Apcin 50 to 100μM on day4 R04 exp176]]|-1.77| |[[:results:exp210|LB-100 2μM R05 exp210]]|-1.77| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|-1.76| |[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-1.75| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-1.74| |[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|-1.71| |[[:results:exp85|UM0129480 7μM R02 exp85]]|-1.7| |[[:results:exp436|Dynasore 7μM R08 exp436]]|1.78| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|1.78| |[[:results:exp230|Epigallocatechin gallate 20μM R05 exp230]]|1.87| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|2.43| |[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|2.46| |[[:results:exp449|Arsenic trioxide 60μM R08 exp449]]|4.24| ^Gene^Correlation^ |[[:human genes:b:bach2|BACH2]]|0.421| Global Fraction of Cell Lines Where Essential: 26/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|1/28| |blood|0/28| |bone|0/26| |breast|6/33| |central nervous system|1/56| |cervix|2/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|1/21| |liver|1/20| |lung|2/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|3/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 16203 * **Expression level (log2 read counts)**: 6.18 {{:chemogenomics:nalm6 dist.png?nolink |}}